• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼日利亚阿达马瓦州的耐多药结核分枝杆菌

MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS IN ADAMAWA STATE, NIGERIA.

作者信息

Omisore Nusirat Omotayo, Oyewole Mukaila Oyeleke, Akinkunmi Ezekiel Olugbenga

机构信息

Department of Pharmacology, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.

Department of Pharmaceutics, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.

出版信息

Afr J Infect Dis. 2018 Dec 12;13(1):39-47. doi: 10.21010/ajid.v13i1.5. eCollection 2019.

DOI:10.21010/ajid.v13i1.5
PMID:30596195
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6305078/
Abstract

BACKGROUND

There is a need to have regular updates from regions where high burden of tuberculosis (TB) have been reported in order to assist the local and global bodies in their objective to curtail the spread of drug resistant TB (DRTB). This study presents a situation report of DRTB in Adamawa State which has been identified as one of the States with high burden of TB in Nigeria.

MATERIALS AND METHODS

Sputum culture in Lowenstein-Jensen Media, drug sensitivity tests and the GeneXpert MTB/Rif analysis were used in the identification and drug susceptibility studies of isolates obtained from forty TB patients who were enrolled from three selected hospitals with DOTS facilities in the State.

RESULTS

The age of TB patients range from 17 to 70 years (median = 30 years). Twenty (50 %) isolates were detected by the GeneXpertMTB/Rif analysis while the media culture detected 31 (77.5%). The two methods however detected rifampicin resistance in 4 (10%) of the total isolates. All rifampicin resistant isolates were multidrug resistant TB (MDRTB) and three of them were from male patients aged 30, 38 and 45. There was only one case of resistance to streptomycin, 3 to ethambutol and 6 to isoniazid. Monoresistance were only observed for ethambutol and isoniazid and it was found in two isolates for each.

CONCLUSION

There is a need to provide interventions to control MDRTB in the state and to make such interventions available and closer to the patients.

摘要

背景

有必要定期从报告结核病(TB)负担较重的地区获取最新信息,以协助地方和全球机构实现遏制耐多药结核病(DRTB)传播的目标。本研究呈现了阿达马瓦州耐多药结核病的情况报告,该州已被确定为尼日利亚结核病负担较重的州之一。

材料与方法

采用罗-琴培养基进行痰培养、药物敏感性试验以及GeneXpert MTB/Rif分析,对从该州三家设有直接观察短程治疗(DOTS)设施的选定医院招募的40例结核病患者分离株进行鉴定和药物敏感性研究。

结果

结核病患者年龄在17至70岁之间(中位数 = 30岁)。通过GeneXpert MTB/Rif分析检测到20株(50%)分离株,而培养基培养检测到31株(77.5%)。然而,两种方法在全部分离株中均检测到4株(10%)对利福平耐药。所有对利福平耐药的分离株均为耐多药结核病(MDRTB),其中3株来自年龄分别为30岁、38岁和45岁的男性患者。仅1例对链霉素耐药,3例对乙胺丁醇耐药,6例对异烟肼耐药。仅观察到对乙胺丁醇和异烟肼的单耐药情况,每种均在2株分离株中发现。

结论

有必要在该州提供控制耐多药结核病的干预措施,并使这些干预措施更接近患者且易于获得。

相似文献

1
MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS IN ADAMAWA STATE, NIGERIA.尼日利亚阿达马瓦州的耐多药结核分枝杆菌
Afr J Infect Dis. 2018 Dec 12;13(1):39-47. doi: 10.21010/ajid.v13i1.5. eCollection 2019.
2
Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.尼日利亚奥孙州胸科诊所就诊的结核病患者中耐多药结核病的流行情况。
Curr Pharm Biotechnol. 2020;21(10):939-947. doi: 10.2174/1389201021666200226100242.
3
Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases.GeneXpert 结核分枝杆菌/利福平快速检测在临床疑似耐多药结核病病例中检测利福平耐药结核分枝杆菌菌株中的应用。
Ann Transl Med. 2016 May;4(9):168. doi: 10.21037/atm.2016.05.09.
4
Prevalence of isoniazid resistance in cases of rifampicin resistance detected on GeneXpert MTB/RIF assay.在GeneXpert MTB/RIF检测中发现的利福平耐药病例中异烟肼耐药的患病率。
Med J Armed Forces India. 2023 Dec;79(Suppl 1):S1-S5. doi: 10.1016/j.mjafi.2021.04.007. Epub 2021 Jun 26.
5
Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia.从埃塞俄比亚西北部本尚古勒-古马兹地区及其周边地区的肺结核患者中分离出的结核分枝杆菌菌株的遗传多样性和耐药模式。
PLoS One. 2020 Apr 8;15(4):e0231320. doi: 10.1371/journal.pone.0231320. eCollection 2020.
6
Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.REBA MTB-Rifa®检测法在快速检测耐利福平结核分枝杆菌中的应用
BMC Infect Dis. 2013 Oct 15;13:478. doi: 10.1186/1471-2334-13-478.
7
Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran.评估GeneXpert MTB/RIF用于测定伊朗西部和西北部新结核病病例中的利福平耐药性。
New Microbes New Infect. 2017 Jul 13;19:117-120. doi: 10.1016/j.nmni.2017.07.002. eCollection 2017 Sep.
8
Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.埃塞俄比亚中部奥罗米亚州阿尔西地区希托萨区原发性和继发性耐多药结核病情况
BMC Public Health. 2016 Jul 18;16:593. doi: 10.1186/s12889-016-3210-y.
9
Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.来自埃塞俄比亚的耐多药结核病疑似患者中结核分枝杆菌菌株的耐药模式及相关危险因素。
PLoS One. 2018 Jun 4;13(6):e0197737. doi: 10.1371/journal.pone.0197737. eCollection 2018.
10
Multidrug resistance and demography of newly diagnosed tuberculosis patients in Cross River State, Nigeria.尼日利亚克罗斯河州新诊断肺结核患者的多药耐药性与人口统计学特征
Int J Mycobacteriol. 2013 Jun;2(2):89-93. doi: 10.1016/j.ijmyco.2013.03.002. Epub 2013 Apr 22.

引用本文的文献

1
Risk factors for rifampicin resistance tuberculosis among patients attending Directly Observed Treatments Centres in Southwestern Nigeria.尼日利亚西南部直接观察治疗中心患者中耐利福平结核病的危险因素。
Pan Afr Med J. 2024 Nov 22;49:87. doi: 10.11604/pamj.2024.49.87.43958. eCollection 2024.

本文引用的文献

1
Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.利奈唑胺剂量:在使结核病的杀菌效果最大化的同时,将毒性和耐药性出现降至最低
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00751-17. Print 2017 Aug.
2
Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.基因分型MTBDRplus检测法在喀麦隆诊断耐多药结核病中的诊断准确性及实用性?一项横断面研究。
BMC Infect Dis. 2017 May 31;17(1):379. doi: 10.1186/s12879-017-2489-3.
3
WHO's End TB Strategy: From stopping to ending the global TB epidemic.世界卫生组织的终止结核病战略:从遏制到终结全球结核病流行。
Indian J Tuberc. 2015 Oct;62(4):196-9. doi: 10.1016/j.ijtb.2015.11.001. Epub 2016 Jan 23.
4
Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials.莫西沙星和加替沙星用于结核病的初始治疗:随机临床试验的荟萃分析
Emerg Microbes Infect. 2016 Feb 24;5(2):e12. doi: 10.1038/emi.2016.12.
5
Tuberculosis among nomads in Adamawa, Nigeria: outcomes from two years of active case finding.尼日利亚阿达马瓦州游牧民中的结核病:两年主动病例发现的结果
Int J Tuberc Lung Dis. 2015 Apr;19(4):463-8. doi: 10.5588/ijtld.14.0679.
6
A four-month gatifloxacin-containing regimen for treating tuberculosis.含加替沙星的四个月疗程治疗结核病。
N Engl J Med. 2014 Oct 23;371(17):1588-98. doi: 10.1056/NEJMoa1315817.
7
Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.南非夸祖鲁-纳塔尔省结核分枝杆菌利福平单耐药:高结核和艾滋病毒流行地区的一个显著现象。
PLoS One. 2013 Nov 6;8(11):e77712. doi: 10.1371/journal.pone.0077712. eCollection 2013.
8
Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria.尼日利亚卡拉巴尔肺结核患者的耐药情况
Pulm Med. 2013;2013:235190. doi: 10.1155/2013/235190. Epub 2013 Aug 26.
9
Global epidemiology of tuberculosis.全球结核病流行病学。
Semin Respir Crit Care Med. 2013 Feb;34(1):3-16. doi: 10.1055/s-0032-1333467. Epub 2013 Mar 4.
10
Prevalence and risk factors associated with drug resistant TB in South West, Nigeria.尼日利亚西南部耐药结核病的流行情况及相关危险因素。
Asian Pac J Trop Med. 2011 Feb;4(2):148-51. doi: 10.1016/S1995-7645(11)60057-6.